Understand the science behind targeted cancer treatments and how they work
Improve confidence in communicating to patients and colleagues about targeted cancer treatments, immunotherapy and biomarkers
Appreciate why so called 'targeted treatments' cause side effects and understand how they impact patients’ quality of life
Recognise some of the current challenges and future potential of targeted cancer treatments
New from February 2020: The world of cancer treatment is changing rapidly, therefore we’ve added new content on immunotherapies, such as checkpoint inhibitors, CAR T cells, PARP inhibitors and CDK inhibitors.
Although the course is open to all, it has been designed primarily for clinical research nurses working with patients on clinical cancer trials, along with clinical cancer research staff and specialist cancer nurses. See more information below.
Thanks to ground-breaking research over the past 20 years, new, more targeted treatments and immunotherapies have been developed that are changing the way we treat cancer, and providing new hope for patients. Join us and discover the science behind these treatments and learn through quizzes, interviews, articles and patient case studies. Each week you’ll have the opportunity to engage in discussion with other learners on key issues. You’ll learn from experts in the field and gain a deeper understanding of how targeted cancer treatments and immunotherapies work to support your patients.
What are targeted treatments and how are they used today
Biological concepts behind targeted cancer treatments and immunotherapies
Principles of cell communication and cancer
Treatments for solid tumours that block cell communication pathways (monoclonal antibodies and kinase inhibitors)
Communicating to patients about targeted cancer treatments
Side effects of treatments and how they impact patients’ quality of life
The unique properties of blood cancers and the targeted therapies used to treat them
The relationship between cancer and the immune system
Various immunotherapy strategies including checkpoint inhibitors, CAR-modified T cells and cancer treatment vaccines
How immunotherapy is reported in the news and managing patient expectations of treatment
The challenges of drug resistance and the implementation of biomarker tests
The future of targeted cancer treatments
This course has been designed primarily for clinical cancer research nurses, along with other members of the clinical cancer research team. It can go towards your Continuing Professional Development (CPD) and/or revalidation with the Nursing and Midwifery Council.
The course is also relevant for and may be of interest to specialist cancer nurses and other health professionals including pharmacists and medical/science graduates studying this topic.
A basic understanding of how cells work is needed to get the most out of this course. Some experience working in cancer is also recommended.